Concentrix’s (CNXC) Buy Rating Reaffirmed at Canaccord Genuity Group

Concentrix (NASDAQ:CNXC – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Canaccord Genuity Group in a report issued on Wednesday, Benzinga reports. They currently have a $45.00 price objective on the stock. Canaccord Genuity Group’s target price points to a potential upside of 73.52% from the stock’s current price.

A number of other equities research analysts have also issued reports on CNXC. Weiss Ratings restated a “sell (d)” rating on shares of Concentrix in a research report on Friday, July 24th. Robert W. Baird lowered their price objective on Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a research report on Tuesday, June 30th. Bank of America lowered their price objective on Concentrix from $32.00 to $26.00 and set a “neutral” rating for the company in a research report on Tuesday, June 30th. Barrington Research lowered their price objective on Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a research report on Tuesday, June 30th. Finally, Zacks Research upgraded Concentrix from a “strong sell” rating to a “hold” rating in a research report on Monday, August 31st. Three analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $32.75.

Get Our Latest Research Report on CNXC

Concentrix Price Performance

Shares of CNXC stock traded up $1.05 during trading hours on Wednesday, reaching $25.93. The company had a trading volume of 2,554,966 shares, compared to its average volume of 1,640,067. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.18 and a current ratio of 1.18. The stock has a fifty day moving average of $27.01 and a 200-day moving average of $26.53. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of -1.22, a PEG ratio of 0.47 and a beta of 0.47. Concentrix has a 12-month low of $19.12 and a 12-month high of $49.37.

Concentrix (NASDAQ:CNXC – Get Free Report) last posted its quarterly earnings results on Tuesday, September 29th. The company reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.71 by $0.21. The business had revenue of $2.45 billion during the quarter, compared to analyst estimates of $2.48 billion. Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The business’s revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the business earned $2.78 earnings per share. Concentrix has set its FY 2026 guidance at 10.970-11.090 EPS and its Q4 2026 guidance at 2.860-2.980 EPS. On average, equities analysts anticipate that Concentrix will post 9.67 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Engineers Gate Manager LP purchased a new position in shares of Concentrix in the second quarter valued at approximately $228,000. Arizona State Retirement System boosted its stake in shares of Concentrix by 14.8% in the second quarter. Arizona State Retirement System now owns 11,783 shares of the company’s stock valued at $264,000 after purchasing an additional 1,523 shares during the period. Nykredit A S purchased a new position in shares of Concentrix in the second quarter valued at approximately $29,000. Corient Private Wealth LP boosted its stake in shares of Concentrix by 321.6% in the second quarter. Corient Private Wealth LP now owns 121,597 shares of the company’s stock valued at $2,724,000 after purchasing an additional 92,752 shares during the period. Finally, Amundi boosted its stake in shares of Concentrix by 46.2% in the second quarter. Amundi now owns 33,437 shares of the company’s stock valued at $749,000 after purchasing an additional 10,572 shares during the period. 90.34% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Concentrix

Here are the key news stories impacting Concentrix this week:

  • Positive Sentiment: Concentrix reported third-quarter adjusted EPS of $2.92, exceeding analysts’ $2.71 consensus and increasing from $2.78 a year earlier. The company also exceeded its profitability guidance and generated record third-quarter operating free cash flow of $268 million, including $218 million in adjusted free cash flow. Concentrix Reports Third Quarter 2026 Results
  • Positive Sentiment: The board raised the quarterly dividend 2.8% to $0.37 per share, or $1.48 annualized. The dividend provides a yield of approximately 5.6%, which may support investor interest in the stock. Concentrix Dividend and Stock Information
  • Positive Sentiment: Canaccord Genuity reaffirmed its “buy” rating and maintained a $45 price target, implying substantial upside from recent trading levels. Management also expects new-business revenue to exceed $6 billion in 2027 and is targeting net leverage of 2.2 times in that year.
  • Neutral Sentiment: Concentrix issued full-year fiscal 2026 EPS guidance of $10.97–$11.09, above the $10.89 analyst consensus. However, its $9.8–$9.9 billion revenue outlook is below the $10.0 billion consensus, indicating stronger profitability but softer sales expectations.
  • Negative Sentiment: Third-quarter revenue was $2.45 billion, below the $2.48 billion consensus and down 1.2% year over year. The mixed results raised concerns about demand and the company’s transition toward AI-enabled services. Concentrix Stock Falls After Earnings as AI Transition Weighs on Revenue
  • Negative Sentiment: Fourth-quarter guidance was notably below expectations: EPS of $2.86–$2.98 versus a $3.08 consensus, and revenue of $2.4–$2.5 billion versus $2.5 billion expected. This weaker near-term outlook is the primary reason CNXC has moved lower despite the quarterly EPS beat.

About Concentrix

(Get Free Report)

Concentrix Corporation is a global technology and services company that helps organizations manage customer experience, business operations and digital transformation. Its offerings include customer care, technical support, sales and marketing services, back-office support, analytics, artificial intelligence and automation solutions.

The company serves clients across industries such as technology and consumer electronics, retail, banking and financial services, healthcare, communications and media, travel, and automotive.

Further Reading

Analyst Recommendations for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.